Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flaherty

Showing results (551-560 of 580) with videos related to

Pageof 58
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant MelanomaGao Zhang, Lawrence W Wu, Ilgen Mender, et al.
Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Cell|November 3, 2018
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, et al.
Cell Reports|June 3, 2026
Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterationsKonstantinos Tsingas, Monzy Thomas, McKenna Reale, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Journal of the National Cancer Institute|January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial DesignKeith T Flaherty, Robert Gray, Alice Chen, et al.
Science (New York, N.Y.)|April 29, 2016
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seqItay Tirosh, Benjamin Izar, Sanjay M Prakadan, et al.
The Journal of Clinical Investigation|April 5, 2016
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitorsGao Zhang, Dennie T Frederick, Lawrence Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
The State of Melanoma: Emergent Challenges and OpportunitiesMichael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
Pageof 58

Showing results (551-560 of 580) with videos related to

Sort By:
Pageof 58
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant MelanomaGao Zhang, Lawrence W Wu, Ilgen Mender, et al.
Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.
Nature Medicine|June 5, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaKelsey R Monson, Robert Ferguson, Joanna E Handzlik, et al.
Cell|November 3, 2018
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, et al.
Cell Reports|June 3, 2026
Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterationsKonstantinos Tsingas, Monzy Thomas, McKenna Reale, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Journal of the National Cancer Institute|January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial DesignKeith T Flaherty, Robert Gray, Alice Chen, et al.
Science (New York, N.Y.)|April 29, 2016
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seqItay Tirosh, Benjamin Izar, Sanjay M Prakadan, et al.
The Journal of Clinical Investigation|April 5, 2016
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitorsGao Zhang, Dennie T Frederick, Lawrence Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
The State of Melanoma: Emergent Challenges and OpportunitiesMichael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
Pageof 58